Recent advances in autophagy-based neuroprotection

References

• Zhou J, Farah BL, Sinha RA, et al. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance. PLoS One 2014;29:e87161
   Google Scholar
• Tooze SA, Yoshimori T. The origin of the autophagosomal membrane. Nat Cell Biol 2010;12:831-5
   PubMed Web of Science ®Google Scholar
• Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science 2004;306:990-5
   PubMed Web of Science ®Google Scholar
• Johansen T, Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011;7:279-96
   PubMed Web of Science ®Google Scholar
• Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007;811:931-7
   Google Scholar
• Mizushima N, Levine B. Autophagy in mammalian development and differentiation. Nat Cell Biol 2010;12:823-30
   PubMed Web of Science ®Google Scholar
• Rabinowitz JD, White E. Autophagy and metabolism. Science 2010;330:1344-8
   PubMed Web of Science ®Google Scholar
• Chen Y, Klionsky DJ. The regulation of autophagy-unanswered questions. J Cell Sci 2011;124:161-70
   PubMed Web of Science ®Google Scholar
• Ravikumar B, Sarkar S, Davies JE, et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 2010;90:1383-435
   PubMed Web of Science ®Google Scholar
• Ryter SW, Choi AM. Autophagy: an integral component of the mammalian stress response. J Biochem Pharmacol Res 2013;1:176-88
   PubMedGoogle Scholar
• Mizushima N, Yamamoto A, Matsui M, et al. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosomes marker. Mol Biol Cell 2004;15:1101-11
   PubMed Web of Science ®Google Scholar
• Alers S, Löffler AS, Wesselborg S, Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol 2012;32:2-11
   PubMed Web of Science ®Google Scholar
• Cheng Y, Ren X, Hait WN, Yang JM. Therapeutic targeting of autophagy in disease: biology and pharmacology. Pharmacol Rev 2013;65:1162-97
   PubMed Web of Science ®Google Scholar
• Kamada Y, Yoshino K, Kondo C, et al. Tor directly controls the Atg1 kinase complex to regulate autophagy. Mol Cell Biol 2010;30:1049-58
   PubMed Web of Science ®Google Scholar
• Stitzel ML, Seydoux G. Regulation of the oocyte-to-zygote transition. Science 2007;316:407-8
   Google Scholar
• Tsukamoto S, Kuma A, Murakami M, et al. Autophagy is essential for preimplantation development of mouse embryos. Science 2008;321:117-20
   PubMed Web of Science ®Google Scholar
• Aburto MR, Juan M, Hurlé JM, et al. Autophagy during vertebrate development. Cells 2012;1:428-48
   Google Scholar
• Tukaj C. The significance of macroautophagy in health and disease. Folia Morphol (Warsz) 2013;72:87-93
   Google Scholar
• Mizushima N. The pleiotropic role of autophagy: from protein metabolism to bactericide. Cell Death Differ 2005;12:1535-41
   PubMed Web of Science ®Google Scholar
• Kroemer G, Levine B. Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 2008;9:1004-10
   PubMed Web of Science ®Google Scholar
• Eskelinen EL, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta 2009;1793:664-73
   PubMed Web of Science ®Google Scholar
• Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011;147:728-41
   PubMed Web of Science ®Google Scholar
• Han J, Pan XY, Xu Y, et al. Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage. Autophagy 2012;8:812-25
   PubMed Web of Science ®Google Scholar
• Gyurus E, Kaposztas Z, Kahan BD. Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: a long-term analysis of various treatment regimens. Transplant Proc 2011;43:1583-92
   PubMed Web of Science ®Google Scholar
• López E, Berna-Erro A, Bermejo N, et al. Long-term mTOR inhibitors administration evokes altered calcium homeostasis and platelet dysfunction in kidney transplant patients. J Cell Mol Med 2013;17:636-47
   Google Scholar
• Deblon N, Bourgoin L, Veyrat-Durebex C, et al. Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats. Br J Pharmacol 2012;165:2325-40
   PubMed Web of Science ®Google Scholar
• He Z, Qiu J, Li J, et al. Long-term effects of conversion from cyclosporine to rapamycin on testicular function and morphology in a rat transplantation model. Transplant Proc 2013;45:763-9
   Google Scholar
• Tooze SA, Schiavo G. Liaisons dangereuses: autophagy, neuronal survival and neurodegeneration. Curr Opin Neurobiol 2008;18:504-15
   PubMed Web of Science ®Google Scholar
• Son JH, Shim JH, Kim KH, et al. Neuronal autophagy and neurodegenerative diseases. Exp Mol Med 2012;29:89-98
   Google Scholar
• Mariño G, Madeo F, Kroemer G. Autophagy for tissue homeostasis and neuroprotection. Curr Opin Cell Biol 2011;23:198-206
   PubMedGoogle Scholar
• Komatsu M, Wang QJ, Holstein GR, et al. Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration. Proc Natl Acad Sci USA 2007;104:14489-94
   PubMed Web of Science ®Google Scholar
• Friedman LG, Lachenmayer ML, Wang J, et al. Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of α-synuclein and LRRK2 in the brain. J Neurosci 2012;32:7585-93
   PubMed Web of Science ®Google Scholar
• Lee JA. Neuronal autophagy: a housekeeper or a fighter in neuronal cell survival? Exp Neurobiol 2012;21:1-8
   PubMedGoogle Scholar
• Hara T, Nakamura K, Matsui M, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006;441:885-9
   PubMed Web of Science ®Google Scholar
• Komatsu M, Chiba T, Mizushima N. Physiological role in constitutive autophagy. Tanpakushitsu Kakusan Koso 2006;51:1515-18
   Google Scholar
• Nixon RA, Wegiel J, Kumar A, et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 2005;64:113-22
   PubMed Web of Science ®Google Scholar
• Jaeger PA, Wyss-Coray T. All-you-can-eat: autophagy in neurodegeneration and neuroprotection. Mol Neurodegener 2009;4:16
   PubMed Web of Science ®Google Scholar
• Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008;451:1069-75
   PubMed Web of Science ®Google Scholar
• Shi R, Weng J, Zhao L, et al. Excessive autophagy contributes to neuron death in cerebral ischemia. CNS Neurosci Ther 2012;18:250-60
   PubMed Web of Science ®Google Scholar
• Morris JK, Honea RA, Vidoni ED, et al. Is Alzheimer’s disease a systemic disease? Biochim Biophys Acta 2014;1842(9):1340-9
   PubMed Web of Science ®Google Scholar
• Casey G. Alzheimer’s and other dementias. Nurs N Z 2012;18:20-4
   Google Scholar
• Blass JP, Ko L, Wisniewski HM. Pathology of Alzheimer’s disease. Psychiatr Clin North Am 1991;14:397-420
   PubMedGoogle Scholar
• Zetterberg H, Blennow K, Hanse E. Amyloid beta and APP as biomarkers for Alzheimer’s disease. Exp Gerontol 2010;45:23-9
   PubMed Web of Science ®Google Scholar
• Obulesu M, Venu R, Somashekhar R. Tau mediated neurodegeneration an insight into Alzheimer’s disease pathology. Neurochem Res 2011;36:1329-35
   PubMed Web of Science ®Google Scholar
• Ansari N, Khodagholi F. Natural products as promising drug candidates for the treatment of Alzheimer’s disease: molecular mechanism aspect. Curr Neuropharmacol 2013;11:414-29
   PubMed Web of Science ®Google Scholar
• Liang JH, Jia JP. Dysfunctional autophagy in Alzheimer’s disease: pathogenic roles and therapeutic implications. Neurosci Bull 2014;30:308-16
   Google Scholar
• Pickford F, Masliah E, Britschgi M, et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest 2008;118:2190-9
   PubMed Web of Science ®Google Scholar
• Nilsson P, Loganathan K, Sekiguchi M, et al. Aβ secretion and plaque formation depend on autophagy. Cell Rep 2013;17:61-9
   Google Scholar
• Tan CC, Yu JT, Tan MS, et al. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy. Neurobiol Aging 2014;35:941-57
   PubMed Web of Science ®Google Scholar
• Cai Z, Yan LJ. Rapamycin, Autophagy, and Alzheimer’s Disease. J Biochem Pharmacol Res 2013;1:84-90
   PubMedGoogle Scholar
• Zhu XC, Yu JT, Jiang T, Tan L. Autophagy modulation for Alzheimer’s disease therapy. Mol Neurobiol 2013;48:702-14
   PubMed Web of Science ®Google Scholar
• Spilman P, Podlutskaya N, Hart MJ, et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer’s disease. PLoS One 2010;5:e9979
   PubMed Web of Science ®Google Scholar
• Caccamo A, Magrì A, Medina DX, et al. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer’s disease and other tauopathies. Aging Cell 2013;12:370-80
   PubMed Web of Science ®Google Scholar
• Liu Y, Su Y, Wang J, et al. Rapamycin decreases tau phosphorylation at Ser214 through regulation of cAMP-dependent kinase. Neurochem Int 2013;62:458-67
   Google Scholar
• Yang Y, Chen S, Zhang J, et al. Stimulation of autophagy prevents amyloid-β peptide-induced neuritic degeneration in PC12 cells. J Alzheimers Dis 2014;40(4):929-39
   PubMed Web of Science ®Google Scholar
• Cai Z, Zhao B, Li K, et al. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer’s disease? J Neurosci Res 2012;90:1105-18
   PubMed Web of Science ®Google Scholar
• Jiang T, Yu JT, Zhu XC, et al. Temsirolimus promotes autophagic clearance of amyloid-β and provides protective effects in cellular and animal models of Alzheimer’s disease. Pharmacol Res 2014;81:54-63
   PubMed Web of Science ®Google Scholar
• Steele JW, Gandy S. Latrepirdine (Dimebon®), a potential Alzheimer therapeutic, regulates autophagy and neuropathology in an Alzheimer mouse model. Autophagy 2013;9:617-18
   PubMed Web of Science ®Google Scholar
• Jeong JK, Moon MH, Lee YJ, et al. Melatonin-induced autophagy protects against human prion protein-mediated neurotoxicity. J Pineal Res 2012a;53:138-46
   PubMed Web of Science ®Google Scholar
• Jeong JK, Moon MH, Bae BC, et al. Autophagy induced by resveratrol prevents human prion protein-mediated neurotoxicity. Neurosci Res 2012b;73:99-105
   PubMed Web of Science ®Google Scholar
• Emanuele E. Can trehalose prevent neurodegeneration? Insights from experimental studies. Curr Drug Targets 2014;15:551-7
   PubMed Web of Science ®Google Scholar
• Li L, Zhang S, Zhang X, et al. Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-β pathology in a mouse model of Alzheimer’s disease. Curr Alzheimer Res 2013;10:433-41
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang X, Teng Z, et al. Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice. Eur J Pharmacol 2014;740:312-20
   PubMed Web of Science ®Google Scholar
• Roy K, Raychaudhuri M, Chakrabarti O, Mukhopadhyay D. Growth factor receptor-bound protein 2 promotes autophagic removal of amyloid-β protein precursor intracellular domain overload in neuronal cells. J Alzheimers Dis 2014;38:881-95
   Google Scholar
• Tian Y, Chang JC, Fan EY, et al. Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer’s APP-CTF for terminal degradation via autophagy. Proc Natl Acad Sci USA 2013;110:17071-6
   PubMed Web of Science ®Google Scholar
• Pacheco-Quinto J, Eckman EA. Endothelin-converting enzymes degrade intracellular β-amyloid produced within the endosomal/lysosomal pathway and autophagosomes. J Biol Chem 2013;288:5606-15
   Google Scholar
• Seidl SE, Santiago JA, Bilyk H, Potashkin JA. The emerging role of nutrition in Parkinson’s disease. Front Aging Neurosci 2014;7:36
   Google Scholar
• Dauer W, Przedborski S. Parkinson’s disease: mechanisms and models. Neuron 2003;39:889-909
   PubMed Web of Science ®Google Scholar
• Xiong N, Xiong J, Jia M, et al. The role of autophagy in Parkinson’s disease: rotenone-based modeling. Behav Brain Funct 2013;15:13
   Google Scholar
• Utsumi H; Cabergoline as the Starting Treatment and its Long-term Effects (CASTLE) Study Group. Long-term effects of cabergoline and levodopa in Japanese patients with early Parkinson’s disease: a 5-year prospective study. Acta Med Okayama 2012;66:163-70
   Google Scholar
• Banerjee R, Beal MF, Thomas B. Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications. Trends Neurosci 2010;33:541-9
   PubMed Web of Science ®Google Scholar
• Dehay B, Bové J, Rodríguez-Muela N, et al. Pathogenic lysosomal depletion in Parkinson’s disease. J Neurosci 2010;30:12535-44
   PubMed Web of Science ®Google Scholar
• Parganlija D, Klinkenberg M, Domínguez-Bautista J, et al. Loss of PINK1 impairs stress-induced autophagy and cell survival. PLoS One 2014;9:e95288
   Google Scholar
• Park HJ, Shin JY, Kim HN, et al. Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a parkinsonian model. Neurobiol Aging 2014;35:1920-8
   Google Scholar
• Pan T, Kondo S, Zhu W, et al. Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement. Neurobiol Dis 2008;32:16-25
   PubMed Web of Science ®Google Scholar
• Pan T, Rawal P, Wu Y, et al. Rapamycin protects against rotenone-induced apoptosis through autophagy induction. Neuroscience 2009;164:541-51
   PubMed Web of Science ®Google Scholar
• Santini E, Heiman M, Greengard P, et al. Inhibition of mTOR signaling in Parkinson’s disease prevents L-DOPA-induced dyskinesia. Sci Signal 2009;2(80):ra36
   Google Scholar
• Decressac M, Mattsson B, Weikop P, et al. TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity. Proc Natl Acad Sci USA 2013;110:817-26
   Google Scholar
• Liu K, Shi N, Sun Y, et al. Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice. Neurochem Res 2013;38:201-7
   PubMed Web of Science ®Google Scholar
• Lin TK, Chen SD, Chuang YC, et al. Resveratrol partially prevents rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through induction of heme oxygenase-1 dependent autophagy. Int J Mol Sci 2014;22:1625-46
   Google Scholar
• Jang W, Kim HJ, Li H, et al. 1,25-Dyhydroxyvitamin D3 attenuates rotenone-induced neurotoxicity in SH-SY5Y cells through induction of autophagy. Biochem Biophys Res Commun 2014;451:142-7
   PubMed Web of Science ®Google Scholar
• Wu Y, Li X, Xie W, et al. Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells. Neurochem Int 2010;57:198-205
   PubMed Web of Science ®Google Scholar
• Filomeni G, Graziani I, De Zio D, et al. Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson’s disease. Neurobiol Aging 2012;33:767-85
   PubMed Web of Science ®Google Scholar
• Cao BY, Yang YP, Luo WF, et al. Paeoniflorin, a potent natural compound, protects PC12 cells from MPP+ and acidic damage via autophagic pathway. J Ethnopharmacol 2010;19:122-9
   Google Scholar
• Kim HJ, Kim J, Kang KS, et al. Neuroprotective effect of Chebulagic acid via autophagy induction in SH-SY5Y Cells. Biomol Ther (Seoul) 2014;22:275-81
   PubMed Web of Science ®Google Scholar
• Ethell D, Fei Q. Parkinson-linked genes and toxins that affect neuronal cell death through the Bcl-2 family. Antioxid Redox Signal 2009;11:529-40
   Google Scholar
• Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-8
   PubMed Web of Science ®Google Scholar
• Geisler S, Holmström KM, Skujat D, et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 2010;12:119-31
   PubMed Web of Science ®Google Scholar
• Palikaras K, Tavernarakis N. Mitophagy in neurodegeneration and aging. Front Genet 2012;19:297
   Google Scholar
• Hattori N, Saiki S, Imai Y. Regulation by mitophagy. Int J Biochem Cell Biol 2014;53:147-50
   Google Scholar
• Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson’s disease caused by mutations in PINK1. Science 2004;304:1158-60
   PubMed Web of Science ®Google Scholar
• Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 2011;12:9-14
   PubMed Web of Science ®Google Scholar
• Siddiqui A, Hanson I, Andersen JK. Mao-B elevation decreases parkin’s ability to efficiently clear damaged mitochondria: protective effects of rapamycin. Free Radic Res 2012;46:1011-18
   PubMed Web of Science ®Google Scholar
• Protter D, Lang C, Cooper AA. α-Synuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson’s Disease? Parkinsons Dis 2012;2012:829207
   Google Scholar
• Wu Y, Li X, Zhu JX, et al. Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson’s disease. Neurosignals 2011;19:163-74
   PubMedGoogle Scholar
• Lan DM, Liu FT, Zhao J, et al. Effect of trehalose on PC12 cells overexpressing wild-type or A53T mutant α-synuclein. Neurochem Res 2012;37:2025-32
   PubMed Web of Science ®Google Scholar
• Hebron ML, Lonskaya I, Moussa CE. Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson’s disease models. Hum Mol Genet 2013;15:3315-28
   Google Scholar
• Höllerhage M, Goebel JN, de Andrade A, et al. Trifluoperazine rescues human dopaminergic cells from wild-type α-synuclein-induced toxicity. Neurobiol Aging 2014;35:1700-11
   Google Scholar
• Collins P, Broekkamp CL, Jenner P, Marsden CD. Effect of chronic trifluoperazine administration and subsequent withdrawal on the production and persistence of perioral behaviours in two rat strains. Psychopharmacology (Berl) 1993;112:437-44
   Google Scholar
• Bashford G, Bradd P. Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report. J Geriatr Psychiatry Neurol 1996;9:133-5
   PubMed Web of Science ®Google Scholar
• Steele JW, Ju S, Lachenmayer ML, et al. Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain. Mol Psychiatry 2013;18:882-8
   Google Scholar
• Gan L, Vargas MR, Johnson DA, Johnson JA. Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model. J Neurosci 2012;32:17775-87
   PubMed Web of Science ®Google Scholar
• Jiang TF, Zhang YJ, Zhou HY, et al. Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson’s disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy. J Neuroimmune Pharmacol 2013;8:356-69
   PubMed Web of Science ®Google Scholar
• Li L, Wang X, Fei X, et al. Parkinson’s disease involves autophagy and abnormal distribution of cathepsin L. Neurosci Lett 2011;489:62-7
   Google Scholar
• Xia LP, Li LY, Fei XF, Liang ZQ. Autophagy is involved in 6-OHDA-induced dopaminergic cell death. Nan Fang Yi Ke Da Xue Xue Bao 2010;30:2649-51
   Google Scholar
• Ross CA, Tabrizi SJ. Huntington’s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 2011;10:83-98
   PubMed Web of Science ®Google Scholar
• Li SH, Cheng AL, Zhou H, et al. Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol 2002;22:1277-87
   PubMed Web of Science ®Google Scholar
• Martin DD, Heit RJ, Yap MC, et al. Identification of a post-translationally myristoylated autophagy-inducing domain released by caspase cleavage of huntingtin. Hum Mol Genet 2014;15:3166-79
   Google Scholar
• Davies SW, Turmaine M, Cozens BA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997;90:537-48
   PubMed Web of Science ®Google Scholar
• Qin ZH, Wang Y, Kegel KB, et al. Autophagy regulates the processing of amino terminal huntingtin fragments. Hum Mol Genet 2003;12:3231-44
   PubMed Web of Science ®Google Scholar
• Cortes CJ, La Spada AR. The many faces of autophagy dysfunction in Huntington’s disease: from mechanism to therapy. Drug Discov Today 2014;19:963-71
   PubMed Web of Science ®Google Scholar
• Jia K, Hart AC, Levine B. Autophagy genes protect against disease caused by polyglutamine expansion proteins in Caenorhabditis elegans. Autophagy 2007;3:21-5
   PubMed Web of Science ®Google Scholar
• Metzger S, Walter C, Riess O, et al. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients. PLoS One 2013;8:e68951
   PubMed Web of Science ®Google Scholar
• Martinez-Vicente M, Talloczy Z, Wong E, et al. Cargo recognition failure is responsible for inefficient autophagy in Huntington’s disease. Nat Neurosci 2010;13:567-76
   PubMed Web of Science ®Google Scholar
• Vodicka P, Lim J, Williams DT, et al. Assessment of chloroquine treatment for modulating autophagy flux in brain of WT and HD mice. J Huntingtons Dis 2014;3:159-74
   PubMedGoogle Scholar
• Ravikumar B, Duden R, Rubinsztein DC. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet 2002;11:1107-17
   PubMed Web of Science ®Google Scholar
• Chen LL, Wu JC, Wang LH, et al. Rapamycin prevents the mutant huntingtin-suppressed GLT-1 expression in cultured astrocytes. Acta Pharmacol Sin 2012;33:385-92
   Google Scholar
• Wu AG, Wong VK, Xu SW, et al. Onjisaponin B derived from Radix Polygalae enhances autophagy and accelerates the degradation of mutant α-synuclein and huntingtin in PC-12 cells. Int J Mol Sci 2013;14:22618-41
   PubMedGoogle Scholar
• Rose C, Menzies FM, Renna M, et al. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington’s disease. Hum Mol Genet 2010;19:2144-53
   PubMed Web of Science ®Google Scholar
• Fernandez-Estevez MA, Casarejos MJ, LópezSendon J, et al. Trehalose reverses cell malfunction in fibroblasts from normal and Huntington’s disease patients caused by proteasome inhibition. PLoS One 2014;9:e90202
   PubMed Web of Science ®Google Scholar
• Wei Y, Sinha S, Levine B. Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation. Autophagy 2008;4:949-51
   PubMed Web of Science ®Google Scholar
• Gump JM, Thorburn A. Autophagy and apoptosis: what is the connection? Trends Cell Biol 2011;21:387-92
   PubMed Web of Science ®Google Scholar
• Yousefi S, Perozzo R, Schmid I, et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 2006;8:1124-32
   PubMed Web of Science ®Google Scholar
• Rubinstein AD, Eisenstein M, Ber Y, et al. The autophagy protein Atg12 associates with antiapoptotic Bcl-2 family members to promote mitochondrial apoptosis. Mol Cell 2011;44:698-709
   PubMed Web of Science ®Google Scholar
• Wirawan E, VandeWalle L, Kersse K, et al. Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis 2010;1:e18
   PubMed Web of Science ®Google Scholar
• Yin X, Cao L, Peng Y, et al. A critical role for UVRAG in apoptosis. Autophagy 2011;7:1242-4
   PubMed Web of Science ®Google Scholar
• Pattingre S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005;122:927-39
   PubMed Web of Science ®Google Scholar
• Maiuri MC, Criollo A, Tasdemir E, et al. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 2007;3:374-6
   PubMed Web of Science ®Google Scholar
• Rikiishi H. Novel insights into the interplay between apoptosis and autophagy. Int J Cell Biol 2012;2012:317645
   PubMedGoogle Scholar
• Zalckvar E, Berissi H, Eisenstein M, Kimchi A. Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL. Autophagy 2009;5:720-2
   PubMed Web of Science ®Google Scholar
• Irmler M, Thome M, Hahne M, et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997;388:190-5
   PubMed Web of Science ®Google Scholar
• Lee JS, Li Q, Lee JY, et al. FLIP-mediated autophagy regulation in cell death control. Nat Cell Biol 2009;11:1355-62
   PubMed Web of Science ®Google Scholar
• Luo S, Rubinsztein DC. Apoptosis blocks Beclin 1-dependent autophagosome synthesis: an effect rescued by Bcl-xL. Cell Death Differ 2010;17:268-77
   PubMed Web of Science ®Google Scholar
• Norman JM, Cohen GM, Bampton ET. The in vitro cleavage of the hAtg proteins by cell death proteases. Autophagy 2010;6:1042-56
   PubMed Web of Science ®Google Scholar
• Oral O, Oz-Arslan D, Itah Z, et al. Cleavage of Atg3 protein by caspase-8 regulates autophagy during receptor-activated cell death. Apoptosis 2012;17:810-20
   PubMed Web of Science ®Google Scholar
• Pagliarini V, Wirawan E, Romagnoli A, et al. Proteolysis of Ambra1 during apoptosis has a role in the inhibition of the autophagic pro-survival response. Cell Death Differ 2012;19:1495-504
   PubMed Web of Science ®Google Scholar